Artificial intelligence in drug discovery: recent advances and future perspectives

José Jiménez-Luna(ETH Zurich), Francesca Grisoni(ETH Zurich), Nils Weskamp(Boehringer Ingelheim (Germany)), Gisbert Schneider(ETH Zurich)
Expert Opinion on Drug Discovery
March 29, 2021
Cited by 452Open Access
Full Text

Abstract

: Deep learning-based approaches have only begun to address some fundamental problems in drug discovery. Certain methodological advances, such as message-passing models, spatial-symmetry-preserving networks, hybrid de novo design, and other innovative machine learning paradigms, will likely become commonplace and help address some of the most challenging questions. Open data sharing and model development will play a central role in the advancement of drug discovery with AI.


Related Papers

No related papers found

Powered by citation graph analysis